Loading clinical trials...
Loading clinical trials...
A randomized, 2-part, 2-sequence, 2-period, open-label, crossover study evaluating the effect of food on the pharmacokinetics (PK) of ORIC-114 tablet formulation in healthy adult subjects.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
ORIC Pharmaceuticals
NCT06988423 · Food Effect in Healthy Participants
NCT03996226 · Food Effect in Healthy Participants
Nucleus Network Pty Ltd., 235 Ryrie St
Geelong, Victoria
Nucleus Network Pty Ltd., Level 5, Burnet Tower, 89 Commercial Rd
Melbourne, Victoria
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions